December 3, 2014 | Teva Pharmaceutical Industries launched a generic equivalent of its Exforge HCT tablets in the United States, a treatment for high blood pressure. Teva was the first company to file for the generic version, and the product will be eligible for 180 days of marketing exclusivity. Exforge HCT is marketed by Novartis Pharmaceuticals and saw annual sales of $158 million in the US. Teva was founded in 1901 by Eli Hurvitz and is headquartered in the US.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
UK Adopts Israeli Counter-Drone Technology
April 25, 2024
Top Tel Aviv Hospital Using AI In Neurological Therapy
April 18, 2024
Facebook comments